Dermatologist Debunks Viral Black Sesame Milk 'Glowing Skin' Trend
A dermatologist has debunked the viral black sesame milk trend, rejecting claims that the drink delivers glowing skin and calling for evidence-based routines instead.
Section
Practice & Policy
Coding, reimbursement, teledermatology and workforce.
In Utah, a $4.99 AI Acne App Can Now Issue Prescriptions
A $4.99 AI app in Utah now issues acne prescriptions as doctors review fewer cases, a shift with implications for access and over…
Dermatology Times Publishes Conferences Calendar for April 2026
Dermatology Times has posted its April 2026 conferences and meetings calendar, though the feed entry names no specific events, da…
Six Dermatologists Named ILDS 2027 Young Achiever Award Winners
The ILDS has named six recipients of its 2027 Young Dermatologist International Achievement Awards, spotlighting early-career der…
SCOTUS Ruling May Push More Malpractice Suits Into Federal Court
A Supreme Court decision may shift more malpractice cases into federal court, Dermatology Advisor reports — a venue change with r…
Dermatologic Surgery Textbooks Show Skin of Colour in Under 9% of Images
A new tally finds under 9 percent of clinical images in dermatologic surgery textbooks show skin of colour, quantifying the visua…
International Cost Comparison Puts HS Biologics Under the Microscope
A new international comparison examines cost efficiency of biologic therapies for hidradenitis suppurativa, with direct implicati…
Mid Florida Dermatology Breach Exposes Data of 85,000 Patients
Roughly 85,000 patients of Mid Florida Dermatology & Plastic Surgery had protected health information exposed in a data breach, T…
Sanofi Signs Letter of Intent With pCPA Covering Dupixent in Four Indications
Sanofi has signed a letter of intent with the pan-Canadian Pharmaceutical Alliance covering Dupixent across four dermatology and…
Safety Group Flags Cancer Evidence Against Popular Unapproved Peptide
On October 13, 2026, the Partnership for Safe Medicines reported mounting evidence linking a popular unapproved peptide to cancer…